Veracyte Operating Income from 2010 to 2024

VCYT Stock

USD 39.59 0.65 1.67%

Veracyte Operating Income yearly trend continues to be comparatively stable with very little volatility. Operating Income is likely to outpace its year average in 2024. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Veracyte generates from its operations. View All Fundamentals

Operating Income

First Reported

2011-12-31

Previous Quarter

4.7 M

Current Value

12 M

Quarterly Volatility

7.9 M

Yuan Drop

Covid

Check Veracyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Veracyte's main balance sheet or income statement drivers, such as Depreciation And Amortization of 28.5 M, Interest Expense of 14.2 K or Selling General Administrative of 165.5 M, as well as many indicators such as Price To Sales Ratio of 5.26, Dividend Yield of 0.0 or PTB Ratio of 1.82. Veracyte financial statements analysis is a perfect complement when working with Veracyte Valuation or Volatility modules.

Check out the analysis of Veracyte Correlation against competitors.

For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.

Latest Veracyte's Operating Income Growth Pattern

Below is the plot of the Operating Income of Veracyte over the last few years. Operating Income is the amount of profit realized from Veracyte operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Veracyte is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Veracyte's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Veracyte's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Veracyte Operating Income Regression Statistics

	Arithmetic Mean	(36,898,683)
	Coefficient Of Variation	(67.98)
	Mean Deviation	19,025,269
	Median	(28,803,000)
	Standard Deviation	25,084,222
	Sample Variance	629.2T
	Range	70.7M
	R-Value	(0.77)
	Mean Square Error	276.4T
	R-Squared	0.59
	Significance	0.0008
	Slope	(4,315,821)
	Total Sum of Squares	8809.1T

Veracyte Operating Income History

	2024	-81.5 M
	2023	-85.8 M
	2022	-41.1 M
	2021	-81.9 M
	2020	-35.4 M
	2019	-15.1 M
	2018	-22.2 M

Other Fundumenentals of Veracyte

Non Operating Income Net Other

Veracyte Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Short Term Investments	Net Tangible Assets	Long Term Debt	Good Will	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Intangible Assets	Short Long Term Debt	Short Term Debt	Net Invested Capital	Net Working Capital	Capital Stock	Current Deferred Revenue
Total Assets		1.0	-0.68	-0.88	0.9	0.97	0.84	0.73	0.81	0.96	0.47	0.87	-0.47	0.97	-0.47	0.99	0.58	0.87	-0.41	0.0	0.79	0.69	0.98	0.9
Total Stockholder Equity	1.0		-0.68	-0.87	0.9	0.97	0.83	0.73	0.8	0.96	0.47	0.87	-0.48	0.97	-0.48	0.99	0.57	0.87	-0.43	-0.02	0.79	0.69	0.98	0.9
Net Debt	-0.68	-0.68		0.69	-0.48	-0.67	-0.52	-0.94	-0.74	-0.56	-0.27	-0.85	0.5	-0.5	0.5	-0.68	-0.7	-0.56	0.47	0.23	-0.61	-0.98	-0.75	-0.42
Retained Earnings	-0.88	-0.87	0.69		-0.75	-0.94	-0.82	-0.75	-0.87	-0.91	-0.4	-0.83	0.19	-0.81	0.19	-0.9	-0.71	-0.73	0.24	-0.13	-0.77	-0.73	-0.87	-0.69
Accounts Payable	0.9	0.9	-0.48	-0.75		0.85	0.78	0.52	0.7	0.91	0.34	0.72	-0.41	0.93	-0.41	0.89	0.31	0.74	-0.34	0.05	0.71	0.45	0.85	0.84
Net Receivables	0.97	0.97	-0.67	-0.94	0.85		0.89	0.75	0.87	0.96	0.51	0.85	-0.33	0.93	-0.33	0.97	0.67	0.87	-0.33	0.07	0.78	0.7	0.96	0.85
Total Liab	0.84	0.83	-0.52	-0.82	0.78	0.89		0.71	0.92	0.84	0.54	0.59	-0.1	0.8	-0.1	0.8	0.66	0.89	-0.13	0.24	0.51	0.54	0.83	0.81
Total Current Assets	0.73	0.73	-0.94	-0.75	0.52	0.75	0.71		0.88	0.62	0.44	0.81	-0.41	0.56	-0.41	0.71	0.78	0.72	-0.4	-0.12	0.59	0.96	0.81	0.51
Common Stock	0.81	0.8	-0.74	-0.87	0.7	0.87	0.92	0.88		0.78	0.52	0.72	-0.19	0.69	-0.19	0.78	0.79	0.82	-0.24	0.09	0.59	0.76	0.83	0.65
Property Plant Equipment	0.96	0.96	-0.56	-0.91	0.91	0.96	0.84	0.62	0.78		0.38	0.81	-0.3	0.96	-0.3	0.97	0.57	0.78	-0.26	0.15	0.79	0.57	0.92	0.85
Short Term Investments	0.47	0.47	-0.27	-0.4	0.34	0.51	0.54	0.44	0.52	0.38		0.41	-0.21	0.42	-0.21	0.4	0.27	0.65	-0.26	-0.1	0.47	0.35	0.5	0.38
Net Tangible Assets	0.87	0.87	-0.85	-0.83	0.72	0.85	0.59	0.81	0.72	0.81	0.41		-0.53	0.79	-0.53	0.9	0.57	0.63	-0.48	-0.14	0.92	0.86	0.9	0.58
Long Term Debt	-0.47	-0.48	0.5	0.19	-0.41	-0.33	-0.1	-0.41	-0.19	-0.3	-0.21	-0.53		-0.43	1.0	-0.45	-0.12	-0.43	0.78	0.64	-0.4	-0.48	-0.53	-0.39
Good Will	0.97	0.97	-0.5	-0.81	0.93	0.93	0.8	0.56	0.69	0.96	0.42	0.79	-0.43		-0.43	0.97	0.44	0.82	-0.37	0.04	0.77	0.52	0.93	0.91
Long Term Debt Total	-0.47	-0.48	0.5	0.19	-0.41	-0.33	-0.1	-0.41	-0.19	-0.3	-0.21	-0.53	1.0	-0.43		-0.45	-0.12	-0.43	0.78	0.64	-0.4	-0.48	-0.53	-0.39
Capital Surpluse	0.99	0.99	-0.68	-0.9	0.89	0.97	0.8	0.71	0.78	0.97	0.4	0.9	-0.45	0.97	-0.45		0.58	0.8	-0.41	0.0	0.84	0.7	0.97	0.85
Deferred Long Term Liab	0.58	0.57	-0.7	-0.71	0.31	0.67	0.66	0.78	0.79	0.57	0.27	0.57	-0.12	0.44	-0.12	0.58		0.62	-0.1	0.13	0.37	0.72	0.63	0.45
Intangible Assets	0.87	0.87	-0.56	-0.73	0.74	0.87	0.89	0.72	0.82	0.78	0.65	0.63	-0.43	0.82	-0.43	0.8	0.62		-0.37	-0.03	0.49	0.61	0.88	0.89
Short Long Term Debt	-0.41	-0.43	0.47	0.24	-0.34	-0.33	-0.13	-0.4	-0.24	-0.26	-0.26	-0.48	0.78	-0.37	0.78	-0.41	-0.1	-0.37		0.91	-0.36	-0.48	-0.46	-0.34
Short Term Debt	0.0	-0.02	0.23	-0.13	0.05	0.07	0.24	-0.12	0.09	0.15	-0.1	-0.14	0.64	0.04	0.64	0.0	0.13	-0.03	0.91		-0.04	-0.23	-0.05	0.03
Net Invested Capital	0.79	0.79	-0.61	-0.77	0.71	0.78	0.51	0.59	0.59	0.79	0.47	0.92	-0.4	0.77	-0.4	0.84	0.37	0.49	-0.36	-0.04		0.62	0.79	0.46
Net Working Capital	0.69	0.69	-0.98	-0.73	0.45	0.7	0.54	0.96	0.76	0.57	0.35	0.86	-0.48	0.52	-0.48	0.7	0.72	0.61	-0.48	-0.23	0.62		0.78	0.44
Capital Stock	0.98	0.98	-0.75	-0.87	0.85	0.96	0.83	0.81	0.83	0.92	0.5	0.9	-0.53	0.93	-0.53	0.97	0.63	0.88	-0.46	-0.05	0.79	0.78		0.85
Current Deferred Revenue	0.9	0.9	-0.42	-0.69	0.84	0.85	0.81	0.51	0.65	0.85	0.38	0.58	-0.39	0.91	-0.39	0.85	0.45	0.89	-0.34	0.03	0.46	0.44	0.85

Click cells to compare fundamentals

About Veracyte Financial Statements

Veracyte shareholders use historical fundamental indicators, such as Operating Income, to determine how well the company is positioned to perform in the future. Although Veracyte investors may analyze each financial statement separately, they are all interrelated. The changes in Veracyte's assets and liabilities, for example, are also reflected in the revenues and expenses on on Veracyte's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Operating Income	-85.8 M	-81.5 M
Non Operating Income Net Other	5.4 M	5.6 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Veracyte Stock Analysis

When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Veracyte Operating Income from 2010 to 2024

Latest Veracyte's Operating Income Growth Pattern

Veracyte Operating Income Regression Statistics

Veracyte Operating Income History

Other Fundumenentals of Veracyte

Veracyte Operating Income component correlations

About Veracyte Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Veracyte Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY